FDA approves first cell-culture vaccine for seasonal influenza
FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines, the first cell-culture-derived vaccine, for individuals aged 18 years of age and older
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
